Crosslink Therapeutics
Crosslink Therapeutics is a startup headquartered in Boston, United States, founded in 2021. It has raised at least $4.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Crosslink Therapeutics has raised at least $4.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Crosslink Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Boston
- 123 See
- 7AI
- Acta Pharmaceuticals
- Acumino
- AdvocateMH
- AI Proteins
- Amplitude Vascular Systems
- Animerra
- Anna Health
- Antares Therapeutics
- Appex Group
Related
- Innovation profile of Boston
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Crosslink Therapeutics do?
Crosslink Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Crosslink Therapeutics raised?
At least $4.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Crosslink Therapeutics based?
Crosslink Therapeutics is headquartered in Boston, United States.
When was Crosslink Therapeutics founded?
Crosslink Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.